Management of Iron Deficiency in a 26-Year-Old Woman
This 26-year-old woman with a serum iron of 27 and transferrin saturation of 6% has confirmed absolute iron deficiency and should begin oral iron supplementation immediately (ferrous sulfate 324 mg daily containing 65 mg elemental iron) while pursuing a focused diagnostic evaluation that prioritizes menstrual history, dietary assessment, and celiac disease screening—with gastrointestinal investigation reserved only if she has GI symptoms, fails to respond to iron therapy, or has concerning features. 1
Diagnostic Confirmation
Your patient's laboratory values confirm absolute iron deficiency:
- Transferrin saturation of 6% is well below the diagnostic threshold of <16% (and even <20%) that confirms depleted iron stores 1, 2
- The serum iron of 27 is also low, supporting the diagnosis 3
- While you haven't provided ferritin, a level <30 μg/L would be diagnostic in this age group without inflammation 3, 4
Initial Clinical Assessment
History Focus
Take a targeted history addressing these specific iron deficiency causes in premenopausal women:
- Menstrual blood loss: Quantify menstrual patterns—heavy or prolonged menstruation is the most common cause in this demographic, affecting 5-10% of menstruating women 3, 1, 2
- Dietary intake: Assess for vegetarian/vegan diet, eating disorders, or restrictive eating patterns that limit heme iron intake 1, 4
- Pregnancy history: Recent pregnancy and breastfeeding deplete iron stores 3, 4
- Medications: Document NSAID use, aspirin, or anticoagulants 3
- GI symptoms: Any abdominal pain, diarrhea, change in bowel habits, or blood in stool 3
Essential Laboratory Testing
Screen for celiac disease with serologic testing (tissue transglutaminase antibody with total IgA level to exclude IgA deficiency), as celiac disease is found in 3-5% of iron deficiency cases and requires specific management beyond iron replacement 3, 1
Treatment Approach
Immediate Iron Supplementation
Start oral iron therapy without delay:
- Ferrous sulfate 324 mg daily (containing 65 mg elemental iron) is the recommended first-line choice 1, 5
- Alternative: 100-200 mg elemental iron daily from any ferrous preparation (ferrous gluconate or ferrous fumarate are equally effective) 1, 6
- Lower doses (28-50 mg elemental iron) may improve compliance by reducing gastrointestinal side effects while maintaining efficacy 4
- Consider ascorbic acid supplementation to enhance absorption if response is poor 3
Expected Response and Monitoring
- Reassess hemoglobin after 2-4 weeks: Expect a rise of ≥10 g/L (or 1-2 g/dL) within 2-4 weeks, which confirms absolute iron deficiency 3, 1, 7
- Continue iron for 3 months after hemoglobin normalization to replenish iron stores 3, 6
- Repeat iron studies after 8-10 weeks of treatment to confirm adequate response 4
When to Investigate Further
GI Investigation NOT Routinely Needed
For premenopausal women under age 45 without concerning features, GI investigation is generally not warranted because menstrual blood loss and/or recent pregnancy are the likely causes, and the prevalence of significant GI pathology (especially malignancy) is very low in non-anemic iron deficiency in this age group 3
Indications for GI Evaluation in This Patient
Pursue endoscopic investigation if:
- Age >45 years (investigate according to standard IDA guidelines with bidirectional endoscopy) 3, 1
- Upper GI symptoms present (dyspepsia, reflux, dysphagia) 3
- Lower GI symptoms (change in bowel habits, rectal bleeding, abdominal pain) 3
- Family history of GI malignancy or inflammatory bowel disease 3
- Failure to respond to oral iron therapy after 4 weeks (hemoglobin fails to rise by 1-2 g/dL) 3, 7
- Recurrent iron deficiency despite adequate supplementation 3
Intravenous Iron Considerations
Reserve IV iron for specific situations:
- Intolerance to at least two different oral iron preparations 3, 1
- Documented malabsorption (confirmed celiac disease, post-bariatric surgery) 1, 2
- Ongoing blood loss that cannot be controlled 1, 2
- Chronic inflammatory conditions (though unlikely in this healthy 26-year-old) 1, 2
Note: Intramuscular iron injections have no role and should not be used (painful, expensive, risk of anaphylaxis with no advantage over oral therapy) 3, 8
Long-Term Management
Follow-Up Monitoring
- Monitor hemoglobin and MCV every 3 months for one year, then annually 3
- For patients with recurrent low ferritin: Consider intermittent oral iron supplementation and monitor iron studies every 6-12 months 4
Critical Pitfall to Avoid
Do not assume dietary deficiency alone without excluding pathologic causes, even though dietary factors are common—a positive dietary history should not preclude appropriate investigation if red flags are present 3, 1
Long-term daily iron supplementation with normal or high ferritin is not recommended and is potentially harmful 4